Molinalogo

Measure

2022

2023

Goal

Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA)

56.88%

57.18%

64.90%

Annual Dental Visits (ADV)

NB

NB

54.60%

Antidepressant Medication Management (AMM) Effective Continuation Phase Treatment

40.69%

40.49%

46.74%

Appropriate Testing for Pharyngitis (CWP)

71.48%

74.29%

77.56%

Appropriate Treatment for Upper Respiratory Infection (URI)

87.41%

86.17%

93.08%

Asthma Medication Ratio (AMR) Total

54.09%

59.88%

69.41%

Avoidance of Antibiotic Treatment for Acute Bronchitis / Bronchiolitis (AAB)

60.62%

63.91%

66.19%

Blood Pressure Control (<140/90) for Patients With Diabetes (BPD)

52.80%

54.74%

68.61%

Breast Cancer Screening (BCS)

49.38%

49.11%

55.25%

Cervical Cancer Screening (CCS)

56.93%

48.22%

59.85%

Childhood Immunization Status (CIS) Combination #10

25.06%

24.57%

35.04%

Chlamydia Screening in Women (CHL) Total

48.80%

51.14%

61.07%

Controlling High Blood Pressure (CBP)

59.85%

51.82%

65.45%

Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD)

78.62%

80.56%

80.86%

Eye Exam for Patients With Diabetes (EED)

53.53%

52.55%

56.20%

Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence (FUA) 7-Day Follow-Up Total

3.38%

18.66%

27.73%

Follow-Up After Emergency Department Visit for Mental Illness (FUM) 7-Day Follow-Up Total

31.60%

30.35%

46.35%

Follow-Up After Hospitalization for Mental Illness (FUH) 7-Day Follow-Up Total

40.45%

37.08%

41.03%

Follow-Up After High-Intensity Care for Substance Use Disorder (FUI) 7-Day Follow-Up Total

26.09%

23.11%

37.31%

Follow-Up Care for Children Prescribed ADHD Medication (ADD) Continuation and Maintenance Phase

40.38%

65.56%

57.90%

Hemoglobin A1c Control for Patients With Diabetes (HBD) HbA1c Control (<8%)

50.61%

50.61%

55.72%

Immunizations for Adolescents (IMA) Combination #2

41.12%

39.17%

38.93%

Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) Engagement of AOD Treatment Total

5.72%

9.68%

16.94%

Kidney Health Evaluation for Patients with Diabetes (KED)

26.85%

29.16%

38.80%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) Blood Glucose and Cholesterol Testing Total

31.34%

33.41%

39.01%

Pharmacotherapy for Opioid Use Disorder (POD) Total

43.01%

41.11%

31.93%

Pharmacotherapy Management of COPD Exacerbation (PCE) Systemic Corticosteroid

73.97%

69.94%

75.79%

Pharmacotherapy Management of COPD Exacerbation (PCE) Bronchodilator

88.81%

86.42%

86.96%

Plan All-Cause Readmissions (PCR) Observed-to-Expected Ratio 18-64 Years

98.09

101.53

≤ 92.72

Prenatal and Postpartum Care (PPC) Timeliness of Prenatal Care

87.35%

81.51%

86.86%

Prenatal and Postpartum Care (PPC) Postpartum Care

68.37%

70.32%

80.78%

Prenatal Immunization Status (PRS) Combination Rate

11.82%

10.61%

25.81

Risk of Continued Opioid Use (COU) 31-Day Total

7.61%

6.03%

≤ 2.45%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total

80.78%

81.03%

81.64%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Statin Adherence 80% Total

65.62%

58.18%

73.63%

Statin Therapy for Patients with Diabetes (SPD) Received Statin Therapy

71.48%

71.08%

67.07%

Statin Therapy for Patients with Diabetes (SPD) Statin Adherence 80%

63.70%

57.52%

70.37%

Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) Total

42.74%

47.79%

63.89%

Use of Imaging Studies for Low Back Pain (LBP)

69.46%

70.93%

75.44%

Use of Opioids at High Dosage (HDO)

4.74%

0.65%

≤ 2.19%

Use of Opioids from Multiple Providers (UOP) Multiple Prescribers and Multiple Pharmacies

1.00%

1.06%

≤ 0.87%

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) BMI Percentile

80.05%

77.37%

83.21%